Literature DB >> 23663314

Ketamine in pain management.

Jan Persson1.   

Abstract

For ketamine's fiftieth birthday, a narrative review of this unique drug in pain management is presented. Its history is traced from its conception, and its heritage, as a phencyclidine offspring, delineated. The earliest roots of the conceptions concerning the mechanisms of action are sought, and then followed in preclinical as well as clinical research. The major proposed mechanisms in the literature are commented on and evaluated. The growth of the clinical evidence for perioperative pain, acute pain, and chronic pain is followed from early attempts to systematic reviews. Finally, an attempt is made to foresee what the next 50 years might hold in store for our 50 years old.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23663314      PMCID: PMC6493592          DOI: 10.1111/cns.12111

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  90 in total

1.  Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.

Authors:  P G Fine
Journal:  J Pain Symptom Manage       Date:  1999-04       Impact factor: 3.612

2.  The semantics of ketamine.

Authors:  S M Green; B Krauss
Journal:  Ann Emerg Med       Date:  2000-11       Impact factor: 5.721

Review 3.  A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief: the role of timing of analgesia.

Authors:  Steen Møiniche; Henrik Kehlet; Jørgen Berg Dahl
Journal:  Anesthesiology       Date:  2002-03       Impact factor: 7.892

4.  Mechanisms of direct inhibitory action of ketamine on vascular smooth muscle in mesenteric resistance arteries.

Authors:  T Akata; K Izumi; M Nakashima
Journal:  Anesthesiology       Date:  2001-08       Impact factor: 7.892

Review 5.  Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions.

Authors:  K Fisher; T J Coderre; N A Hagen
Journal:  J Pain Symptom Manage       Date:  2000-11       Impact factor: 3.612

Review 6.  Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes.

Authors:  Roger L Schmid; Alan N Sandler; Joel Katz
Journal:  Pain       Date:  1999-08       Impact factor: 6.961

7.  A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain.

Authors:  Avi A Weinbroum
Journal:  Anesth Analg       Date:  2003-03       Impact factor: 5.108

Review 8.  Ketamine as an adjuvant to opioids for cancer pain.

Authors:  R Bell; C Eccleston; E Kalso
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 9.  Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.

Authors:  Rae F Bell; Christopher Eccleston; Eija Kalso
Journal:  J Pain Symptom Manage       Date:  2003-09       Impact factor: 3.612

10.  Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.

Authors:  I Oye; O Paulsen; A Maurset
Journal:  J Pharmacol Exp Ther       Date:  1992-03       Impact factor: 4.030

View more
  32 in total

1.  Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site.

Authors:  Nathan G Glasgow; Madeleine R Wilcox; Jon W Johnson
Journal:  Neuropharmacology       Date:  2018-05-12       Impact factor: 5.250

Review 2.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

3.  Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.

Authors:  Nathan G Glasgow; Nadezhda V Povysheva; Andrea M Azofeifa; Jon W Johnson
Journal:  J Neurosci       Date:  2017-09-06       Impact factor: 6.167

Review 4.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

5.  Oral ketamine analgesia in chronic pain and problematic rise in blood pressure.

Authors:  Oliver van Hecke; Bruce Guthrie
Journal:  BMJ Case Rep       Date:  2014-11-25

6.  Morphine with adjuvant ketamine versus higher dose of morphine alone for acute pain: a meta-analysis.

Authors:  Xibing Ding; Shuqing Jin; Xiaoyin Niu; Tingting Wang; Xiang Zhao; Hao Ren; Yao Tong; Quan Li
Journal:  Int J Clin Exp Med       Date:  2014-09-15

7.  Ketamine Inhibition of the Pentameric Ligand-Gated Ion Channel GLIC.

Authors:  Bogdan F Ion; Marta M Wells; Qiang Chen; Yan Xu; Pei Tang
Journal:  Biophys J       Date:  2017-08-08       Impact factor: 4.033

Review 8.  Recent insights into the mode of action of memantine and ketamine.

Authors:  Jon W Johnson; Nathan G Glasgow; Nadezhda V Povysheva
Journal:  Curr Opin Pharmacol       Date:  2014-12-02       Impact factor: 5.547

9.  Ketamine Infusion Therapy as an Alternative Pain Control Strategy in Patients with Multi-Trauma including Rib Fracture; Case Report and Literature Review.

Authors:  Ashley K Losing; Justin M Jones; Adis Keric; Steven E Briggs; David D Leedahl
Journal:  Bull Emerg Trauma       Date:  2016-07

10.  The absolute bioavailability of racemic ketamine from a novel sublingual formulation.

Authors:  Paul Rolan; Stephen Lim; Vivian Sunderland; Yandi Liu; Valeria Molnar
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.